"10.1371_journal.pone.0107762","plos one","2014-10-08T00:00:00Z","Per-Olof Eriksson; Emil Aaltonen; Rodrigo Petoral; Petter Lauritzson; Hideki Miyazaki; Kristian Pietras; Sven Månsson; Lennart Hansson; Peter Leander; Oskar Axelsson","Spago Nanomedical, Lund, Sweden; Department of Laboratory Medicine Lund, Division of Translational Cancer Research, Lund University, Lund, Sweden; Department of Medical Radiation Physics, Lund University, Skåne University Hospital, Malmö, Sweden; Department of Radiology, Lund University, Skåne University Hospital, Malmö, Sweden; Department of Medical Biochemistry and Biophysics, Division of Vascular Biology, Karolinska Institutet, Stockholm, Sweden","Conceived and designed the experiments: PEO EA OA. Performed the experiments: PEO EA P. Lauritzson SM RP LH P. Leander OA. Analyzed the data: PEO EA P. Leander SM KP HM OA. Contributed reagents/materials/analysis tools: KP. Wrote the paper: PEO EA P. Lauritzson SM RP P. Leander OA KP HM.","The authors of this manuscript declare the following competing interests: Per-Olof Eriksson, Emil Aaltonen, Rodrigo Petoral Jr., Petter Lauritzson, Lennart Hansson, and Oskar Axelsson are employees at Spago Nanomedical AB. Sven Månsson was financially compensated by Spago Nanomedical AB for operating the MRI instrument, but not for his expertise as an independent scientist in evaluation of the results. Rodrigo Petoral Jr., Petter Lauritzson and Oskar Axelsson are authors of a patent which concerns Spago Pix (Patent WO 2013041623 A1, titled “Novel manganese comprising nanostructures.” Peter Leander is a member of the board for Spago Nanomedical. There are no additional patents, products in development or marketed products to declare. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.","2014","10","Per-Olof Eriksson","POE",10,TRUE,3,3,3,3,TRUE,TRUE,TRUE,3,"5;7;8",TRUE
